These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36876355)

  • 1. Autoimmune encephalitis : Part 1 (Epidemiology, Pathophysiology and Clinical spectrum).
    Hiesgen J; Schutte C
    S Afr Med J; 2023 Mar; 113(3):116-121. PubMed ID: 36876355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guest editorial.
    Hiesgen J; Schutte C
    S Afr Med J; 2023 Mar; 113(3):115. PubMed ID: 36876357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment.
    Nissen MS; Ryding M; Meyer M; Blaabjerg M
    CNS Neurol Disord Drug Targets; 2020; 19(8):584-598. PubMed ID: 32640967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
    Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
    Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune epilepsy in children: case series and proposed guidelines for identification.
    Suleiman J; Brilot F; Lang B; Vincent A; Dale RC
    Epilepsia; 2013 Jun; 54(6):1036-45. PubMed ID: 23551014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An Update on Therapeutic Management in Autoimmune Encephalitis].
    Kamei S
    Brain Nerve; 2023 May; 75(5):479-484. PubMed ID: 37194516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models.
    Dalmau J; Armangué T; Planagumà J; Radosevic M; Mannara F; Leypoldt F; Geis C; Lancaster E; Titulaer MJ; Rosenfeld MR; Graus F
    Lancet Neurol; 2019 Nov; 18(11):1045-1057. PubMed ID: 31326280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Encephalitis: NMDA Receptor Encephalitis as an Example of Translational Neuroscience.
    Kolls BJ; O'Keefe YA; Sahgal AK
    Neurotherapeutics; 2020 Apr; 17(2):404-413. PubMed ID: 32394329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
    Irani SR; Bera K; Waters P; Zuliani L; Maxwell S; Zandi MS; Friese MA; Galea I; Kullmann DM; Beeson D; Lang B; Bien CG; Vincent A
    Brain; 2010 Jun; 133(Pt 6):1655-67. PubMed ID: 20511282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.
    Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L
    Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
    Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
    Front Immunol; 2021; 12():719432. PubMed ID: 34975832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Autoimmune Encephalitis and Its Relationship With Infection.
    Li Q; Fu N; Han Y; Qin J
    Pediatr Neurol; 2021 Jul; 120():27-32. PubMed ID: 33964702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology].
    Iizuka T; Sakai F
    Brain Nerve; 2008 Sep; 60(9):1047-60. PubMed ID: 18807939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune encephalitis. Anti-NMDA receptor and new immunophenotypes].
    Erazo Torricelli R
    Medicina (B Aires); 2019; 79 Suppl 3():54-59. PubMed ID: 31603845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizures in autoimmune encephalitis-A systematic review and quantitative synthesis.
    Yeshokumar AK; Coughlin A; Fastman J; Psaila K; Harmon M; Randell T; Schorr EM; Han H; Hoang H; Soudant C; Jette N
    Epilepsia; 2021 Feb; 62(2):397-407. PubMed ID: 33475161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune encephalitis: Epidemiology, pathophysiology and clinical spectrum (part 2).
    Hiesgen J; Schutte CM
    S Afr Med J; 2023 Apr; 113(4):e875. PubMed ID: 37283152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune Epilepsy.
    Gaspard N
    Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):227-45. PubMed ID: 26844739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encephalitis associated with antibodies against the NMDA receptor.
    Guasp M; Dalmau J
    Med Clin (Barc); 2018 Jul; 151(2):71-79. PubMed ID: 29183618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical issues in measuring autoantibodies to neuronal cell-surface antigens in autoimmune neurological disorders: 190 cases.
    Kaneko J; Kanazawa N; Tominaga N; Kaneko A; Suga H; Usui R; Ishima D; Kitamura E; Akutsu T; Yoshida K; Nishiyama K; Iizuka T
    J Neurol Sci; 2018 Jul; 390():26-32. PubMed ID: 29801900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.